Арилжаа BioLife Solutions Inc - BLFS CFD

Арилжааны нөхцөл

• Төрөл: CFD
• Спред: 0.29
• Лонг позицын шөнийн санхүүжилтийн тохируулга: -0.02143%
• Шорт позицын нэг шөнийн санхүүжилтийн тохируулга: -0.00079%
• Шөнийн санхүүжилтийг тохируулах хугацаа: 21:00 (UTC)
• Валют: USD
• Арилжаалсан доод хэмжээ: 1
• Маржин: 5.00%
• Хөрөнгийн бирж: United States of America
• Арилжааны шимтгэл: 0%
• Баталгаат стопын шимтгэл: 1%

Гол үзүүлэлтүүд

• Өмнөх Хаах: 21.11
• Нээх: 20.82
• 1 жилийн өөрчлөлт: -9.71%
• Өдрийн диапазон: 20.67 - 21.14

Арилжаа BioLife Solutions Inc - BLFS CFD

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company''s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.